CAT
Caterpillar Inc.
CAT's fundamentals are strong, but it looks expensive: trading at 24x earnings, above its usual 18x. Analysts expect strong earnings growth, though they disagree widely on how much.
NEOV
NeoVolta Inc.
There isn't enough reported data to score NEOV yet.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
NEOV Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Unavailable | |
| Unavailable |
NEOV's revenue is currently healthy, but its profitability is weak. There isn't enough data to rate its cash flow and balance sheet.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
NEOV PE Valuation
NEOV has no meaningful PE right now: it lost money over the past year.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
NEOV Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect NEOV's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over NEOV on earnings quality, reporting a profit while its opponent remains loss making.
NEOV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.55 | -$0.40 |
| Q1 2026 | -$0.33 | -$0.21 |
| Q4 2025 | -$0.29 | -$0.19 |
| Q3 2025 | -$0.16 | -$0.07 |
| Q2 2025 | -$0.15 | -$0.08 |
| Q1 2025 | -$0.12 | -$0.06 |
| Q4 2024 | -$0.10 | -$0.04 |
| Q3 2024 | -$0.09 | -$0.02 |
NEOV lost $0.55 per share over the past year, and its loss has widened in each of the last nine quarters.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over NEOV on profitability, with a higher operating margin.
NEOV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $13.5K | -100% |
| Q1 2026 | $2M | +0.5% |
| Q4 2025 | $4.6M | +334% |
| Q3 2025 | $6.7M | +1027% |
| Q2 2025 | $4.8M | +720% |
| Q1 2025 | $2M | +609% |
| Q4 2024 | $1.1M | +5.3% |
| Q3 2024 | $590.2K | -23% |
NEOV has the edge over CAT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -75670% | -75640 points |
| Q1 2026 | -130% | -62 points |
| Q4 2025 | -96% | -8 points |
| Q3 2025 | -13% | +151 points |
| Q2 2025 | -30% | +97 points |
| Q1 2025 | -68% | +143 points |
| Q4 2024 | -88% | -33 points |
| Q3 2024 | -164% | -107 points |
NEOV's operating margin was −75670% last quarter, down 75640 points from the same quarter a year ago, near the bottom of its range since 2019.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the stronger cash trend. Its trailing FCF is up 39% versus its history, compared with NEOV at down 486%.
NEOV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$7.1M | -$6.2M |
| Q4 2025 | -$2.1M | -$1.2M |
| Q3 2025 | -$2.5M | -$1.9M |
| Q2 2025 | -$924.2K | -$896.7K |
| Q1 2025 | -$2.1M | -$1.6M |
| Q4 2024 | -$858.3K | -$533.9K |
| Q3 2024 | -$593K | -$413.9K |
| Q2 2024 | -$27.5K | +$1.4M |
NEOV has burned cash in almost every quarter: −$13M over the past year, against −$4M the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over NEOV on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
NEOV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +15% | +5.2M shares |
| 1 year | +19% | +6.5M shares |
| 3 years | +21% | +7M shares |
| 5 years | +115% | +21.5M shares |
| Available history | +249% | +28.7M shares |
NEOV has 40M diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
NEOV Net Leverage
NEOV's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
NEOV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.5 | Neutral |
| Stochastic | 24.3 | Neutral |
NEOV's weekly RSI is 50 (neutral) and its Stochastic is 24 (neutral).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
NEOV PE vs Industrials Sector
NEOV has no meaningful PE right now: it lost money over the past year.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
NEOV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.48 | 15% above |
| 20 week MA | $2.76 | 3.3% above |
| 50 week MA | $3.06 | 6.9% below |
| 100 week MA | $3.45 | 17% below |
| 200 week MA | $3.02 | 5.6% below |
NEOV has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 5.6% below its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over NEOV on returns for 2026, with the stronger performance.
NEOV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.41 | $4.25 | +201% |
| 2021 | $4.25 | $6.45 | +52% |
| 2022 | $6.45 | $3.22 | -50% |
| 2023 | $3.22 | $1.60 | -50% |
| 2024 | $1.60 | $5.45 | +241% |
| 2025 | $5.45 | $2.97 | -46% |
| 2026 YTD | $2.97 | $2.85 | -4% |
NEOV's yearly returns have swung widely, from +241% in 2024 to −50% in 2023. It's down 4% so far in 2026.